Crossmark

ASO Author Reflections: Surgical Radicality Versus Aggressive Biology: Small Bowel and Ileocecal Involvement Predict Poorer Survival Despite Complete Cytoreduction in FIGO IIIC–IV Tubo-Ovarian and Primary Peritoneal Carcinoma

Crossref DOI link: https://doi.org/10.1245/s10434-026-19529-w

Published Online: 2026-04-27

Published Print: 2026-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Runnebaum, Ingo B.

Kather, Angela
Funding

Funding for this research was provided by:

Universitätsklinikum Jena
License Information

Text and Data Mining valid from 2026-04-27

Version of Record valid from 2026-04-27
More Information

Article History

Received: 11 March 2026

Accepted: 12 March 2026

First Online: 27 April 2026

Disclosure

: IBR is a founding member of the Ovarian Tumor Committee of the German Gynecologic Oncology Group (AGO) and member of the author team releasing the national ‘S3 Guideline on Diagnosis, Treatment, and Follow-up of Malignant Ovarian Tumors.’ AK declares no conflicts of interest.

Document is current

Any future updates will be listed below